Bulk drug manufacturers seek support from govt, regulatory authorities
Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara Reddy
Pharma MSMEs ask government to extend incentives of PLI scheme
‘Essential’ pharmaceuticals amid disrupted supply chains- A legal nightmare!
COVID-19 restricts Indian pharma export growth to 7.6 per cent in FY’20
IICT, LAXAI LifeSciences collaborate for key pharma intermediates
Restrategising to survive and thrive
Will the industry sell COVID-19 meds at the min production costs?
DGFT lifts export restriction on 12 molecules; paracetamol, HCQ on license basis
No shortage of APIs and formulations in the country, says Government
Page 1 of 4
Page 3 of 4
Page 4 of 4